Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Thrombocytopenia after COVID-19 vaccination

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. Intestinal permeability in type 1 diabetes: An updated comprehensive overview

    Publikation: Bidrag til tidsskriftReviewpeer review

Vis graf over relationer

The objective of this study was to assess the cumulative prevalence of pre-existing comorbidities among patients diagnosed with systemic lupus erythematosus (SLE) in Denmark. The study included patients aged ≥18 years at the index date set to the date of first registration of SLE in the Danish National Patient Registry (DNPR) between 1996 and 2018. Up to 19 age- and sex-matched general population comparators per case were selected. Comorbidity diagnoses were retrieved from the DNPR based on International Classification of Diseases codes. We estimated cumulative prevalence of various comorbidities among cases and comparators, prevalence differences (PDs), and prevalence ratios (PRs), with PDs and PRs adjusted for age and sex, at the index date and 1, 2, 5, and 10 years before the index date. We identified 3,010 SLE cases and 57,046 comparators (mean age at index date: 47.3 years). Most comorbidities occurred more often in SLE patients versus comparators at the index date and up to 10 years before. Overrepresented comorbidities in SLE patients 10 years before SLE diagnosis included neuropsychiatric, cardiovascular, and venous thromboembolic diseases; PDs (95% CI) were 2.3% (1.4-3.3%), 1.3% (0.6-1.9%), and 1.1% (0.6-1.5%), respectively; corresponding PRs (95% CI) were 1.5 (1.3-1.8), 1.7 (1.4-2.1), and 4.3 (3.1-6.1). We found a higher prevalence of multiple comorbidities-not only at the time of SLE diagnosis but likewise during the 10-year pre-diagnosis period-among individuals with SLE. These findings underscore the importance of early clinical vigilance toward comorbidities starting in the diagnostic phase of SLE.

OriginalsprogEngelsk
Artikelnummer102692
TidsskriftJournal of Autoimmunity
Vol/bind123
Sider (fra-til)102692
ISSN0896-8411
DOI
StatusUdgivet - sep. 2021

Bibliografisk note

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

ID: 73994346